Determination of the antibacterial and lipopolysaccharide-neutralizing regions of guinea pig neutrophil cathelicidin peptide CAP11

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 8, 2006, Pages 2602-2607

  Okuda, Daiju ^a   Yomogida, Shin ^a   Tamura, Hiroshi ^b   Nagaoka, Isao ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SEIKAGAKU CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; NEUTROPHIL CATHELICIDIN PEPTIDE CAP11; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIMERIZATION; DISULFIDE BOND; DRUG ACTIVITY; DRUG DETERMINATION; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; GUINEA PIG; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL LINE; DIMERIZATION; DISULFIDES; ESCHERICHIA COLI; GUINEA PIGS; LIPOPOLYSACCHARIDES; MACROPHAGES; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; NEUTROPHILS; STAPHYLOCOCCUS AUREUS;

EID: 33746865989     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00331-06     Document Type: Article

References (39)

1. Braff, M. H., M. A. Hawkins, A. Di Nardo, B. Lopez-Garcia, M. D. Howell, C. Wong, K. Lin, J. E. Streib, R. Dorschner, D. Y. Leung, and R. L. Gallo. 2005. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J. Immunol. 174:4271-4278.
2. Dankesreiter, S., A. Hoess, J. Schneider-Mergener, H. Wagner, and T. Miethke. 2000. Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock. J. Immunol. 164:4804-4811.
3. David, S. A. 2001. Towards a rational development of anti-endotoxin agents: novel approaches to sequestration of bacterial endotoxins with small molecules. J. Mol. Recognit. 14:370-387.
4. DeForge, L. E., K. L. Billeci, and S. M. Kramer. 2000. Effect of IFN-gamma on the killing of S. aureus in human whole blood. Assessment of bacterial viability by CFU determination and by a new method using alamarBlue. J. Immunol. Methods 245:79-89.
5. Elssner, A., M. Duncan, M. Gavrilin, and M. D. Wewers. 2004. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J. Immunol. 172:4987-4994.
6. Gennaro, R., and M. Zanetti. 2000. Structural features and biological activities of the cathelicidin-dcrived antimicrobial peptides. Biopolymers 55:31-49.
7. Gudmundsson, G. H., and B. Agerberth. 1999. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. J. Immunol. Methods 232:45-54.
8. Hancock, R. E., and G. Diamond. 2000. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8:402-410.
9. Hancock, R. E., and M. G. Scott. 2000. The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. USA 97:8856-8861.
10. Hoess, A., S. Watson, G. R. Siber, and R. Liddington. 1993. Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 Å resolution. EMBO J. 12:3351-3356.
11. Iwagaki, A., M. Porro, and M. Pollack. 2000. Influence of synthetic antiendotoxin peptides on lipopolysaccharide (LPS) recognition and LPS-induccd proinflammatory cytokine responses by cells expressing membrane-bound CD14. Infect. Immun. 68:1655-1663.
12. Kirikae, T., M. Hirata, H. Yamasu, F. Kirikae, H. Tamura, F. Kayama, K. Nakatsuka, T. Yokochi, and M. Nakano. 1998. Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia. Infect. Immun. 66:1861-1868.
13. Kluver, E., S. Schulz-Maronde, S. Scheid, B. Meyer, W. G. Forssmann, and K. Adermann. 2005. Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. Biochemistry 44:9804-9816.
14. Larrick, J. W., M. Hirata, R. F. Balint, J. Lee, J. Zhong, and S. C. Wright. 1995. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect. Immun. 63:1291-1297.
15. Larrick, J. W., M. Hirata, J. Zhong, and S. C. Wright. 1995. Anti-microbial activity of human CAP18 peptides. Immunotechnology 1:65-72.
16. Lehrer, R. I., and T. Ganz. 2002. Cathelicidins: a family of endogenous antimicrobial peptides. Curr. Opin. Hematol. 9:18-22.
17. Lehrer, R. I., and T. Ganz. 2002. Defensins of vertebrate animals. Curr. Opin. Immunol. 14:96-102.
18. Lehrer, R. I., A. K. Lichtenstein, and T. Ganz. 1993. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol. 11:105-128.
19. Levy, O. 2000. Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood 96:2664-2672.
20. Martin, E., T. Ganz, and R. I. Lehrer. 1995. Defensins and other endogenous peptide antibiotics of vertebrates. J. Leukoc. Biol. 58:128-136.
21. Matsuzaki, K. 1999. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta 1462:1-10.
22. + cells. J. Immunol. 167:3329-3338.
23. Nagaoka, I., S. Hirota, F. Niyonsaba, M. Hirata, Y. Adachi, H. Tamura, S. Tanaka, and D. Heumann. 2002. Augmentation of the lipopolysaccharide- neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin. Diagn. Lab. Immunol. 9:972-982.
24. Nagaoka, I., S. Hirota, S. Yomogida, A. Ohwada, and M. Hirata. 2000. Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm. Res. 49:73-79.
25. Nagaoka, I., K. Kuwahara-Arai, H. Tamura, K. Hiramatsu, and M. Hirata. 2005. Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substitutions. Inflamm. Res. 54:66-73.
26. Nagaoka, I., Y. Tsutsumi-Ishii, S. Yomogida, and T. Yamashita. 1997. Isolation of cDNA encoding guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and evaluation of CAP11 mRNA expression during neutrophil maturation. J. Biol. Chem. 272:22742-22750.
27. Nagaoka, I., S. Yomogida, H. Tamura, and M. Hirata. 2004. Antibacterial cathelicidin peptide CAP11 inhibits the lipopolysaccharide (LPS)-induced suppression of neutrophil apoptosis by blocking the binding of LPS to target cells. Inflamm. Res. 53:609-622.
28. Porro, M. 1994. Structural basis of endotoxin recognition by natural polypeptides. Trends Microbiol. 2:65-67.
29. Risso, A. 2000. Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity. J. Leukoc. Biol. 68:785-792.
30. Sawa, T., K. Kurahashi, M. Ohara, M. A. Gropper, V. Doshi, J. W. Larrick, and J. P. Wiener-Kronish. 1998. Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model. Antimicrob. Agents Chemother. 42:3269-3275.
31. Scocchi, M., I. Zelezetsky, M. Benincasa, R. Gennaro, A. Mazzoli, and A. Tossi. 2005. Structural aspects and biological properties of the cathelicidin PMAP-36. FEBS J. 272:4398-4406.
32. Seydel, U., A. B. Schromm, R. Blunck, and K. Brandenburg. 2000. Chemical structure, molecular conformation, and bioactivity of endotoxins. Chem. Immunol. 74:5-24.
33. Tenover, F. C., J. M. Swenson, C. M. O'Hara, and S. A. Stocker. 1995. Ability of commercial and reference antimicrobial susceptibility testing methods to detect vaneomycin resistance in enterococci. J. Clin. Microbiol. 33:1524-1527.
34. Tossi, A., L. Sandri, and A. Giangaspero. 2000 Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55:4-30.
35. Tsutsumi-Ishii, Y., T. Hasebe, and I. Nagaoka. 2000. Role of CCAAT/enhancer-binding protein site in transcription of human neutrophil peptide-1 and -3 defensin genes. J. Immunol. 164:3264-3273.
36. VanderMeer, T. J., M. J. Menconi, J. Zhuang, H. Wang, R. Murtaugh, C. Bouza, P. Stevens, and M. P. Fink. 1995. Protective effects of a novel 32-amino acid C-terminal fragment of CAP18 in endotoxemic pigs. Surgery 117:656-662.
37. Yajko, D. M., J. J. Madej, M. V. Lancaster, C. A. Sanders, V. L. Cawthon, B. Gee, A. Babst, and W. K. Hadley. 1995. Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis. J. Clin. Microbiol. 33:2324-2327.
38. Yomogida, S., I. Nagaoka, and T. Yamashita. 1996. Purification of the 11- and 5-kDa antibacterial polypeptides from guinea pig neutrophils. Arch. Biochem. Biophys. 328:219-226.
39. Zanetti, M., R. Gennaro, and D. Romeo. 1995. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374:1-5.